xrimatistirio.com
ELEN
Διαθέσιμο και στα ελληνικά. Δες το στα ελληνικά →
← Back to dashboard
Medicon Hellas logo
MEDICHealthcare · Diagnostics & Research · ΧΑ

Medicon Hellas

€3.11
+0.00(+0.00%)
Close 26/10/2026 · end-of-day price, not real-time

Medicon Hellas (MEDIC) closed at €3.11 on 26/10/2026, +0.00% on the day. Market cap €13.7m, P/E 10.4, dividend yield 4.82%.

My view
Private · MENTOR takes it into account
+26.4%6M
Drag sideways across the chart to pick a period, or click an event's dot below it, then ask MENTOR about it.
26/10/2026Close 3.11+0.00%+26.4% since start

Key statistics

FY2025 unless a figure says otherwise

Profile

At the 26 Oct close
Market value
€13.7m
Enterprise valueDec 2025est.
€12.6m
Shares outstandingOct 2026
4.4m
RevenueFY2025
€18m
Employees
152
Free floatest.
55.3%
Traded a day, 3-month average
€9.7k

Valuation

FY2025
P/EFY2023
10.4×
P/B
0.71×
EV/Salesest.
0.70×
EV/EBITDAest.
3.3×

5 years, on reported full years: 2.2–4.8×, median 3.1×. Today 3.3×, higher than 58% of months.

P/FCF
4.7×
Dividend yield
4.8%

Margins

FY2025
Gross
73.1%
EBITDA
21.0%
Operating (EBIT)
12.6%
Pre-tax
11.5%
Net
9.6%
Free cash flow
16.2%

Net margin = the shareholders' profit ÷ group revenue.

Returns

FY2025
ROCE
11.4%
ROICest.
9.8%
ROA
5.4%
Tax rate
14.6%
Profit to minority holders
2.2%

Financial health

Dec 2025
Cash
€6.7m
Net debt
−€1.4m
Net debt ÷ EBITDA
−0.38×
Interest coverFY2025
12.0×

Growth

Revenue, last yearFY2025
−2.3%
Revenue, 3 yearsFY2022–25, a year
−4.7%
Revenue, 5 yearsFY2020–25, a year
+3.3%

Dividends

FY2025
Yield, last 12 months
4.8%
Per share
€0.150
Covered by free cash flow
4.4×
Years paid, last fiveFY2021–25
4

Trading and risk

From our closes, dividends reinvested
Total return, 1 year
+26.6%
3 years, a year
+5.8%
5 years, a year
+2.6%
10 years, a year
+25.8%
Volatility, 1 year
30.5%
Beta to the General Index
0.61×
Deepest fall, 1 year / 5 years
−13.1% / −60.5%
52-week range
€2.39–€3.12
est.worked out by usread with care: tap for why

Where the figures come from: the company's reports, reviewed by us · annual accounts filed in ESEF format · results announcements on the exchange · our own closing prices. No forecasts or target prices are stored.

Financial charts

From the stored figures: the reviewed dossier first, then the annual reports (ESEF) and results announcements

Loading the charts…

Valuation

no like-for-like peer
MetricMEDIC
P/E10.4
P/B0.71
P/S0.77
EV/EBITDA3.3
Dividend yield4.8%
Gross margin73.1%
Operating margin12.6%
Net margin9.6%
Revenue growth (last full year)−2.3%
Net debt−€1.4m
Twelve Data · latest quarter 31/12/2025

Peers: Diagnostics

No other company listed in Athens runs this business; related ones can be ticked in.

EV/EBITDADay
Medicon HellasMEDIC3.3+0.0%
Athens Medical CenterIATR9.9+0.0%

The company

AI-drafted

Makes in-vitro diagnostic reagents in Gerakas, distributes foreign analysers and reagents, and runs three private diagnostic laboratories (Megalab). Customers are mainly public hospitals and insurance funds in Greece, with exports about 17% of sales.

How it makes moneyFY2025 · basis: revenue
  • Medical reagents and analysers184.9%
  • Diagnostic laboratories113.5%
  • Cosmetics11.6%
It is
  • A Greek maker of diagnostic reagents that also distributes foreign analysers and has three small labs.1,4
  • Family-influenced: three Dimotsantos holders own 44.71%.1
It is not
  • Not a drug maker: it sells medical consumables and runs diagnostic centres.4
  • Not reliant on private payers: the State and funds dominate its receivables.1
Recent developmentsAll company events →
  • Sep 2026H1 2026 results: revenue €9.52m (+7.6%), owners' profit €1.52m against €0.79m.2
  • Jul 2026The €0.15 FY2025 dividend per share, payable from 17 July.5
  • Jun 2026The AGM re-elects the seven-member board for six years, four of them independent.7,8
  • Apr 2026FY2025 results: profit after tax up 32.6% to €1.77m.4
  • Jul 2025Payment of the €0.13 FY2024 dividend per share, from 11 July.6
  • Jul 2024Sale of the 50.90% stake in Pliroforiki Ellados to IKnowHealth for €356,291.9,3
Key figures
  • Revenue €17.95m FY20251
  • EBITDA €3.77m FY20251
  • Net income (owners) €1.73m FY20251
  • Net cash €2.85m H1 20262
  • Dividend per share €0.15 FY20255
Key facts
  • Own-made products are 47% of sales, merchandise 39% and lab services 14%.1
  • Hospitals and EFKA owe 82% of trade receivables; customers pay in 161 days on average.1
  • In H1 2026 revenue rose 7.6% and EBITDA 47%.2
  • A €0.15 dividend with payment starting 17 July 2026 and 5% withholding tax.5
  • About €5.1m of restructured loans falls due on 31 December 2027; cash and deposits were €11.7m in June 2026.10,11,2
Sources
  1. 1.Annual report 2025Medicon Hellas S.A. · 30/04/2026official
  2. 2.Half-year report 2026Medicon Hellas S.A. · 30/09/2026official
  3. 3.Annual report 2024Medicon Hellas S.A. · 25/04/2025official
  4. 4.Results announcement FY2025Medicon Hellas S.A. · 30/04/2026official
  5. 5.Dividend FY2025 noticeMedicon Hellas S.A. · 30/06/2026official
  6. 6.Dividend FY2024 noticeMedicon Hellas S.A. · 26/06/2025official
  7. 7.AGM decisions 30 June 2026Medicon Hellas S.A. · 30/06/2026official
  8. 8.Board and committees 30 June 2026Medicon Hellas S.A. · 30/06/2026official
  9. 9.Sale of 50.90% of Pliroforiki ElladosMedicon Hellas S.A. · 12/07/2024official
  10. 10.Annual report 2018Medicon Hellas S.A. · 18/04/2019official
  11. 11.Annual report 2019Medicon Hellas S.A. · 18/06/2020official
AI-drafted from the cited sources · 05/10/2026 · v1 · ✓ checked by an independent second modelMedicon Hellas S.A.Website ↗
MENTORFree beta
Why it moved
Flat · volume 0.1×
News & events
News and what's next
Peers
No listed peers
Results
How it did vs last year
Valuation
No listed peers
More
Asks“What's the latest news on Medicon Hellas, and what's coming up?”
Data: Twelve Data · End-of-day prices · Nothing here is investment advice.